Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus
暂无分享,去创建一个
Michael Gale | A. García-Sastre | M. Gale | Y. Loo | L. Martínez-Sobrido | Washington B Cárdenas | Masaki Mibayashi | Luis Martínez-Sobrido | Yueh-Ming Loo | Washington B. Cárdenas | Adolfo García-Sastre | M. Mibayashi
[1] S. Goodbourn,et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] G. Kochs,et al. The interferon response circuit: Induction and suppression by pathogenic viruses , 2005, Virology.
[3] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[4] A. García-Sastre,et al. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[5] Z. Zhai,et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.
[6] Osamu Takeuchi,et al. Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.
[7] H. Klenk,et al. The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.
[8] Nicole M. Bouvier,et al. Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins , 2003, Journal of Virology.
[9] R. Krug,et al. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[11] R. Webby,et al. Mutations in the NS1 Protein of Swine Influenza Virus Impair Anti-Interferon Activity and Confer Attenuation in Pigs , 2005, Journal of Virology.
[12] R. Tsien,et al. A monomeric red fluorescent protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Bluyssen,et al. The interferon-stimulated gene 54 K promoter contains two adjacent functional interferon-stimulated response elements of different strength, which act synergistically for maximal interferon-alpha inducibility. , 1994, European journal of biochemistry.
[14] Adolfo Garcia-Sastre,et al. Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication , 2000, Journal of Virology.
[15] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[16] F. Weber,et al. Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner , 2005, Journal of Virology.
[17] J. Hiscott,et al. MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.
[18] R. Flavell,et al. TLR-Independent Induction of Dendritic Cell Maturation and Adaptive Immunity by Negative-Strand RNA Viruses1 , 2004, The Journal of Immunology.
[19] Osamu Takeuchi,et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.
[20] B. Prasad,et al. X-ray structure of influenza virus NS1 effector domain , 2006, Nature Structural &Molecular Biology.
[21] M. Katze,et al. Global Host Immune Response: Pathogenesis and Transcriptional Profiling of Type A Influenza Viruses Expressing the Hemagglutinin and Neuraminidase Genes from the 1918 Pandemic Virus , 2004, Journal of Virology.
[22] Robert H. Silverman,et al. Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains , 2002, Journal of Virology.
[23] A. García-Sastre,et al. Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.
[24] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[25] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[26] S. Elankumaran,et al. Recombinant Newcastle disease virus as a vaccine vector. , 2003, Poultry science.
[27] Zhijian J. Chen,et al. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.
[28] A. García-Sastre,et al. Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein , 2005, Journal of Virology.
[29] A. García-Sastre,et al. A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice , 2003, Journal of Virology.
[30] Thorsten Wolff,et al. The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors , 2002, Journal of Virology.
[31] S. Lemon,et al. Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.
[32] A. García-Sastre,et al. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[33] H. Katinger,et al. Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes , 2004, Journal of Virology.
[34] K. Tyler,et al. Does Toll-like receptor 3 play a biological role in virus infections? , 2004, Virology.
[35] M. Brunda,et al. Interferons and Other Cytokines , 1997 .
[36] R. Krug,et al. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. , 2006, Virology.
[37] D. Levy,et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.
[38] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[39] A. García-Sastre,et al. Recombinant Newcastle Disease Virus as a Vaccine Vector , 2001, Journal of Virology.
[40] Z. Zhai,et al. VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .
[41] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[42] D. Levy,et al. IRF3 and IRF7 Phosphorylation in Virus-infected Cells Does Not Require Double-stranded RNA-dependent Protein Kinase R or IκB Kinase but Is Blocked by Vaccinia Virus E3L Protein* , 2001, The Journal of Biological Chemistry.
[43] William M. Lee,et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] Christine A. Biron,et al. Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente , 2006, Science.
[45] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[46] Qiang Sun,et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKε Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage , 2006, Journal of Virology.
[47] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[48] Helen M. Berman,et al. Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein , 1997, Nature Structural Biology.
[49] Amer A. Beg,et al. Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.
[50] F. Hayden,et al. Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responses , 2001, Journal of medical virology.
[51] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[52] R. Krug,et al. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. , 2003, Virology.
[53] A. Bowie,et al. Viral Activation of Macrophages through TLR-Dependent and -Independent Pathways1 , 2004, The Journal of Immunology.
[54] M. Severa,et al. Tumor Necrosis Factor Alpha Enhances Influenza A Virus-Induced Expression of Antiviral Cytokines by Activating RIG-I Gene Expression , 2006, Journal of Virology.
[55] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[56] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] F. Weber,et al. Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses , 2006, Journal of Virology.
[58] Roger E Bumgarner,et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza , 2002, Proceedings of the National Academy of Sciences of the United States of America.